12:00 AM
 | 
Jul 30, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

Clopidogrel Genetic Absorption Activation Panel regulatory update

Transgenomic said it received Medicare coverage for its Clopidogrel Genetic Absorption Activation Panel as an aid to predict a patient's response to cardiovascular drug Plavix clopidogrel. The test detects...

Read the full 134 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >